-
公开(公告)号:WO2020123861A1
公开(公告)日:2020-06-18
申请号:PCT/US2019/066066
申请日:2019-12-12
IPC分类号: C07C59/70 , C07C69/736 , C07C235/20 , A61P25/00
摘要: Compounds are provided having the following structure of Formula (I) or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein X1, X2, and R1 are as defined herein. Such compounds function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their use and preparation.
-
公开(公告)号:WO2020118564A1
公开(公告)日:2020-06-18
申请号:PCT/CN2018/120634
申请日:2018-12-12
摘要: Compounds are provided having the structure of Formula (I) : (I) or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein X 1 , X 2 , and R 1 are as defined herein. Such compounds function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their use and preparation.
-